| Code | Description | Claims | Beneficiaries | Total Paid |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
9,650 |
7,962 |
$491K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,117 |
7,461 |
$423K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
10,043 |
8,406 |
$410K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,356 |
4,334 |
$393K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,777 |
4,510 |
$203K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,944 |
6,374 |
$185K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,726 |
2,448 |
$173K |
| 94060 |
|
1,384 |
1,338 |
$76K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
297 |
296 |
$29K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,519 |
1,466 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
594 |
544 |
$13K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
462 |
452 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
443 |
423 |
$3K |
| 94664 |
|
177 |
175 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
116 |
113 |
$2K |
| 90655 |
|
70 |
67 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
29 |
28 |
$2K |
| 90674 |
|
54 |
53 |
$2K |
| 81002 |
|
697 |
675 |
$1K |
| 87807 |
|
125 |
113 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
13 |
$671.58 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
29 |
28 |
$530.43 |
| 93000 |
|
12 |
12 |
$394.68 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
64 |
63 |
$381.98 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
42 |
42 |
$257.19 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
36 |
36 |
$164.47 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,528 |
1,479 |
$62.18 |
| 81025 |
|
13 |
13 |
$36.40 |
| G0008 |
Administration of influenza virus vaccine |
13 |
13 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
20 |
20 |
$0.00 |